Table 4 Cohort-level demographic and clinical rating tool scores of all participants.

From: A multimodal dataset of real world mobility activities in Parkinson’s disease

 

Parkinson’s disease participants

Control participants

Mean (standard deviation)

Mean (standard deviation)

Age (years)

61.25 (8.5)

59.25 (13.4)

Number of men (%)

7 (58)

3 (25)

MDS-UPDRS total score

“On” = 44.8 (16.1); “off = 61.7 (29.9)

6.8 (4.8)

MDS-UPDRS III sub score

“On” = 19.1 (10.4); “off” = 36.8 (23.0)

2.8 (1.9)

PIGD sub score

“On” = 2.8 (1.9); “off” = 4.3 (4.8)

0.1 (0.3)

TUG-test time

“On” = 8.3 (2.1); “off” = 10.8 (5.1)

7.0 (1.5)

PDQ-39

23.3 (14.2)

 

RBD-SQ

6.8 (3.3)

 

PDSS

118.9 (14.2)

 

NMSS

31.8 (17.4)

 

Hoehn and Yahr “off” medications

2.3 (0.8)

 

Years since diagnosis

8.2 (6.5)

 

LEDD

517.5 (395.7)

 
  1. MDS-UPDRS: Movement Disorder Society sponsored revision of the Unified Parkinson’s Disease Rating Scale; PIGD: Postural Instability and Gait Difficulties sub-score of MDS-UPDRS; TUG-test: Timed-Up-and-Go test; PDQ-39: Parkinson’s Disease Questionnaire-39; RBD-SQ: REM sleep Behaviour Disorder Screening Questionnaire; PDSS: Parkinson’s Disease Sleep Scale; NMSS: Non-Motor Symptoms Scale for Parkinson’s disease; LEDD: levodopa equivalent daily dose.